EpiFinder
EpiFinder is a proprietary app software which helps doctors to effectively diagnose epilepsy syndromes at the point-of-care. #healthIT #startup #yesphx.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| N/A | $200k | Seed | |
| Total Funding | 000k | ||
Related Content
Epifinder operates in the healthcare technology sector, focusing on improving the diagnosis and management of epilepsy. The company offers a global screening tool designed to address the frequent misdiagnosis of epilepsy, a neurological disorder characterized by uncontrollable seizure episodes. Serving both patients and healthcare professionals, Epifinder's core product is a Behavioral Self Management Tool that allows patients to document their seizures, medications, and daily lifestyle activities. This data aids doctors in interpreting symptoms and improving diagnostic accuracy.
The market Epifinder operates in includes over 65 million people worldwide who live with epilepsy, encompassing 62 different epilepsy syndromes. The company's business model revolves around providing software solutions that enhance the diagnostic process, standardize care practices, and ultimately improve the quality of life for epilepsy patients. Revenue is generated through the sale of its software solutions to healthcare providers, including neurologists, nurse practitioners, and physician assistants.
Keywords: epilepsy, diagnostic tool, seizure management, healthcare software, patient documentation, neurological disorder, misdiagnosis, standardize care, quality of life, healthcare professionals.